Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec 1;51(12):1156-1159.
doi: 10.3899/jrheum.2024-0951.

Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms

Kaveh Ardalan  1 , Lisa G Rider  2
Affiliations
Editorial

Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms

Kaveh Ardalan et al. J Rheumatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest:

KA: Cabaletta Bio (advisory board, consultant); Childhood Arthritis and Rheumatology Research Alliance (consultant, Juvenile Dermatomyositis Committee Vice Chair)

LGR: Cure JM Foundation, Hope Pharmaceuticals, Cabaletta Bio, Horizon, Pfizer (advisory board, unpaid consultant)

References

    1. Rider LG, Aggarwal R, Machado PM, et al. Update on outcome assessment in myositis. Nat Rev Rheumatol 2018;14:303–18. - PMC - PubMed
    1. Aggarwal R, Rider LG, Ruperto N, et al. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol 2017;69:898–910. - PMC - PubMed
    1. Rider LG, Aggarwal R, Pistorio A, et al. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol 2017;69:911–23. - PMC - PubMed
    1. Miller FW, Rider LG, Chung YL, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatol Oxf 2001;40:1262–73. - PubMed
    1. Aggarwal R, Charles-Schoeman C, Schessl J, et al. Trial of Intravenous Immune Globulin in Dermatomyositis. N Engl J Med 2022;387:1264–78. - PubMed

Publication types

LinkOut - more resources